J Autism Dev Disord by Wiggins, Lisa D. et al.
Brief Report: The ADOS Calibrated Severity Score Best 
Measures Autism Diagnostic Symptom Severity in Pre-School 
Children
Lisa D. Wiggins1, Brian Barger2, Eric Moody3, Gnakub Soke1, Juhi Pandey4, and Susan 
Levy4
1National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control 
and Prevention, 4770 Buford Highway MS E-86, Atlanta, GA 30341, USA
2Georgia State University School of Public Health, Atlanta, GA, USA
3University of Colorado School of Medicine, Aurora, CO, USA
4Center for Autism Research, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
Abstract
The severity of autism spectrum disorder (ASD) is often measured by co-occurring conditions, 
such as intellectual disability or language delay, rather than deficits in social interaction, and 
restricted interests and repetitive behaviors. The Autism Diagnostic Observation Schedule 
calibrated severity score (ADOS CSS) was created to facilitate comparison of the diagnostic 
features of ASD independent of related conditions over time. We examined the relationship 
between the ADOS CSS, ADOS total score, and clinician rated degree of impairment (DOI) in the 
Study to Explore Early Development. Like others, we confirmed that, among the measures we 
evaluated, the ADOS CSS was least influenced by developmental functioning and demographic 
factors and is therefore the best measure of core features of ASD in pre-school children.
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Introduction
Autism spectrum disorder (ASD) is a developmental disorder characterized by deficits in 
social communication and interaction, and the presence of restricted interests and repetitive 
behaviors that are recognized in early childhood (American Psychiatric Association 2013). 
ASD is considered a spectrum disorder because of the varied nature of symptom 
presentation and range of behavioral, developmental, and medical conditions that co-occur 
with ASD (Levy et al. 2010). ASD severity is often defined and influenced by the presence 
of co-occurring conditions, such as behavior problems, intellectual disability, language 
delay, motor delay, and sleep disturbance (Gotham et al. 2012; Jang et al. 2011; Jang and 
Matson 2015; MacDonald et al. 2014; Schreck et al. 2004; Shumway et al. 2012). These co-
occurring conditions are notable components of adaptive functioning and treatment selection 
but are not diagnostic features of ASD. It is important to measure the severity of diagnostic 
features of ASD independent of related conditions, so the influence on outcomes can be 
gauged separately. Moreover, a measure of the severity of diagnostic features of ASD could 
help describe phenotypes and assess response to treatment over time.
Gotham et al. (2009) addressed the need for a standardized measure of ASD symptom 
severity by calibrating total scores from the Autism Diagnostic Observation Schedule 
(ADOS), the gold-standard instrument to quantify symptoms of and diagnose ASD (Lord et 
al. 1999). ADOS total scores—a simple sum of raw scores on diagnostic items— have 
previously been used as a measure of ASD severity. However, ADOS total scores are 
influenced by chronological age and language aptitude, which prevents comparison of ASD 
severity in different groups of children over time. Gotham et al., thus, created a calibrated 
severity score (CSS) to facilitate comparison of the diagnostic features of ASD independent 
of child age and related conditions. Children with ASD (n = 1118) were placed into age and 
language cells and ADOS CSS were generated within each cell based on percentiles of raw 
total scores (Gotham et al. 2009). Less variance in the ADOS CSS was explained by factors 
such as expressive language ability and maternal education than the ADOS total score. 
Therefore, the ADOS CSS was less influenced by developmental functioning and 
demographic factors than the ADOS total score. These findings were later supported by 
Shumway and colleagues (2012) who also found that the ADOS CSS was useful in 
controlling for differences in verbal development. Both sets of authors concluded that the 
ADOS CSS was a useful measure of ASD symptom severity in clinical, genetic, and 
neurobiological research.
Although, the ADOS CSS seems to measure ASD diagnostic symptoms independently from 
intellectual ability and language aptitude, other variables associated with ASD symptom 
severity were not included in previous analyses. First, past studies did not evaluate the effect 
of behavior problems (i.e., internalizing and externalizing behaviors) and sleep disturbance 
on severity measures. Second, clinical judgment is a critical component of the diagnosis of 
ASD; however, it is not clear how well it captures core ASD symptoms independently of 
related symptoms. Including clinical judgment as a measure of ASD severity would help 
determine the influence of developmental and demographic variables on clinician global 
impressions and how clinical judgment compares with the ADOS CSS and ADOS total 
score. Another limitation of prior analyses is the broad age range of participants (i.e., 2–16 
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years in the Gotham et al. (2009) sample and 2–12 years in the Shumway et al. (2012) 
sample). Limiting the sample to pre-school aged children would help define whether the 
ADOS CSS is less influenced by child and demographic characteristics than the ADOS total 
score in early childhood.
The objectives for the current study were two-fold: (1) to examine the correlation between 
the ADOS CSS, ADOS total score, and clinical impression of degree of impairment (DOI) 
among children classified as ASD in a case-control study to demonstrate a linear and 
positive relationship between these three measures of ASD severity and (2) determine which 
of these three measures was least influenced by developmental functioning and demographic 
factors. The Study to Explore Early Development (SEED) is a multi-site case-control study 
of risk factors of ASD in children 2–5 years of age. As part of SEED, children with ASD 
were given the ADOS among a host of other developmental and parent-report measures; 
clinicians also noted their clinical judgment on the degree of impairment associated with 
ASD symptoms for each child evaluated in SEED. Based on previous research, we predicted 
high correlations between the ADOS CSS, ADOS total score, and SEED DOI, and that the 
ADOS CSS would be least influenced by developmental and demographic characteristics.
Method
Participant Ascertainment
SEED is a case-control study conducted in California, Colorado, Georgia, Maryland, North 
Carolina, and Pennsylvania, and approved by Institutional Review Boards at each site and at 
the Centers for Disease Control and Prevention. Eligible children were born between 
September 1, 2003 and August 31, 2006, enrolled into the study between 2 and 5 years of 
age, resided in one of the study areas, and lived with a knowledgeable caregiver who was 
competent to communicate in English (or in California and Colorado, in English or 
Spanish). Three groups of children were recruited from each site: (1) those with known ASD 
and (2) those with known developmental delays identified from multiple educational and 
health providers or family or physician referral, and (3) those from the general population 
identified from state vital records. A detailed description of the SEED eligibility criteria, 
ascertainment methods, response rates, enrollment methods, and data collection procedures 
can be found in Schendel and colleagues (2012).
Data Collection Procedures
The Social Communication Questionnaire (SCQ) (Rutter et al. 2003) was administered to all 
families to provide an initial assessment of ASD risk and guide further assessment 
procedures. An SCQ score of 11 points or higher was chosen as an indicator of ASD risk, 
based on research that indicating it maximizes sensitivity and specificity in young children 
(Lee et al. 2007; Wiggins et al. 2007). Families of children who obtained a score of 11 or 
higher on the SCQ, had a previous ASD diagnosis, or demonstrated ASD behaviors during 
the clinic visit were asked to complete the Autism Diagnostic Interview—Revised (ADI-R) 
(Lord et al. 1994), ADOS (Lord et al. 1999), Mullen Scales of Early Learning (MSEL) 
(Mullen 1995), and Vineland Adaptive Behavior Scales—Second Edition (VABS-II) 
(Sparrow et al. 2005), along with the Child Behavior Checklist (CBCL) (Achenbach 1992). 
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Clinicians who administered the ADI-R and ADOS established research reliability before 
study start and quarterly thereafter (i.e., 90% agreement with consensus scores on the ADI-R 
and 80% agreement with consensus scores on the ADOS).
Clinicians who evaluated the child noted the degree of impairment associated with ASD 
(SEED DOI) on a 7-point Likert scale, with 1 point indicating little impairment and 7 points 
indicating high impairment (Schendel et al. 2012; Wiggins et al. 2015). Children were not 
assigned SEED DOI values of 0 because the child had to demonstrate some ASD risk to 
receive a comprehensive SEED evaluation. Clinicians also noted whether ASD symptoms 
were better accounted for by another disorder; children with symptoms accounted for by 
another disorder were excluded from this analysis because our sample was limited to 
children with ASD.
ASD Case Status
The SEED ASD case status algorithm was based on best practice guidelines (Johnson et al. 
2007), review of the literature on ASD classification, clinical experience among members of 
a clinical workgroup, and a desire to create a uniform method of characterizing ASD 
symptoms in large cohorts of children. ASD case status was based on the results of gold-
standard ASD diagnostic instruments rather than previous diagnosis. Children classified as 
ASD were those who met ASD criteria on both the ADI-R (a comprehensive parent 
interview) and the ADOS (a direct assessment of the child) or who met ASD criteria on the 
ADOS and one of three alternate criteria on the ADI-R (i.e., met criteria on the social 
domain and was within two points on the communication domain, met criteria on the 
communication domain and was within two points on the social domain, or met criteria on 
the social domain and had two points noted on the behavioral domain). Details on the SEED 
final classification algorithm can be found in Wiggins et al. (2015).
Statistical Methods
The relationship between the ADOS CSS, ADOS total score, and SEED DOI was assessed 
with a bivariate correlation matrix. Pearson correlation coefficients of 0.50 or greater were 
considered to represent a large effect size (Cohen 1988). Similar to Gotham et al. (2009), the 
influence of developmental and demographic factors on severity outcomes was evaluated 
with hierarchical linear regressions. The following developmental variables were entered 
into the first block: CBCL externalizing behavior t-scores (derived from attention problems 
and aggressive behavior subscales), CBCL internalizing behavior t-scores (derived from 
emotionally reactive, anxious/depressed, somatic complaints, and withdrawn subscales), 
CBCL sleep problems t-scores, MSEL expressive language t-scores, MSEL fine motor t-
scores, MSEL receptive language t-scores, MSEL visual reception t-scores, and VABS-II 
Adaptive Behavior Composite (VABS-II ABC). The following demographic and other 
variables were entered into the second block: child ethnicity, child race, child sex, maternal 
education, and SEED site. These demographic and other variables are those that could affect 
ASD symptoms but have less influence when child factors are controlled (Gotham et al. 
2009). We did not include child age in the regression models since the age range of our 
participants was restricted to children 2–5 years. All statistical analyses were conducted 
using SPSS version 20.0.
Wiggins et al. Page 4
J Autism Dev Disord. Author manuscript; available in PMC 2018 September 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Results
A total of 707 children were classified as ASD after a comprehensive SEED evaluation. Of 
these, 92.5% had a SEED DOI and were included in these analyses; 3.25% children had a 
note that ASD symptoms were better accounted for by another disorder, and 4.25% children 
had missing DOI data. The mean age of children in the study was 59.4 months (range 34.5–
70.6 months; SD 6.69 months), and 82.0% of the sample was male. The race of child 
participants was 57.4% White, 19.0% Black, 12.2% Multiracial, and 11.4% other race. A 
total of 15.8% of the sample identified as Hispanic ethnicity. Among mothers, 1.80% had 
missing education data, 20.1% completed high school or less, 28.3% completed some 
college, 31.0% completed a Bachelor’s degree, and 18.8% completed a Master’s degree or 
higher.
The relationship between the ADOS CSS, ADOS total score, and SEED DOI is outlined in 
Table 1. All three measures of severity were positively correlated in bivariate comparisons, 
and all effects were statistically significant.
Results of hierarchical linear regression analyses are presented in Tables 2, 3 and 4. The 
total amount of variance in ASD symptom severity accounted for by developmental and 
demographic characteristics was 17% for the ADOS CSS, R2 = 0.17, F(19, 608) = 6.66, p < .
001; 41% for the ADOS total score, R2 = 0.41, F(19, 608) = 22.61, p < . 001; and 53% for 
the SEED DOI, R2 = 0.53, F(19, 608) = 33.98, p < .001. In all three models, the Δ R2 was 
statistically significant when adding demographic factors (Model 2) to developmental level 
only factors (Model 1) (for all models p < .001). In all three models, developmental 
characteristics influenced ratings of ASD symptom severity more than did demographic 
characteristics (Tables 2, 3, 4). Higher ratings of all three ASD symptom severity measures 
were associated with more internalizing behavior problems and fewer adaptive behavior 
skills, expressive language abilities, and fine motor abilities (Tables 2, 3, 4). SEED site and 
maternal education were also statistically significant terms in the ADOS CSS, ADOS total 
score, and SEED DOI models.
Discussion
Measuring ASD symptom severity independent of other developmental and demographic 
factors provides quantification of the core symptoms of ASD for various research and 
treatment paradigms. The goals of this study were to examine the relationship between the 
ADOS CSS, ADOS total score, and SEED DOI among children classified as ASD in SEED 
and determine which of these three measures of ASD severity was least influenced by 
developmental and demographic characteristics. Results of the correlation analysis showed 
that the ADOS CSS was significantly and positively related to the ADOS total score and 
SEED DOI; results of the linear regression analyses showed that the ADOS CSS reduced the 
effects of co-occurring conditions and demographic features on the severity of ASD 
diagnostic symptoms more so than other measures of ASD severity. Our study findings are 
in agreement with those of Gotham et al. (2009) and others that assessed children into 
school-age and suggest that, among the measures we evaluated, the ADOS CSS is the best 
measure of core features of ASD in pre-school children.
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Adaptive behavior skills explained a significant amount of variance of ASD symptom 
severity, with the SEED DOI having the strongest relationship with the VABS-II ABC, 
followed by the ADOS total score then ADOS CSS. Poor adaptive behavior is a common co-
occurring condition for children with ASD and may partially result from core deficits in 
social and communication skills also measured on adaptive tests (Kanne et al. 2010). 
However, a global measure of adaptive behavior such as the VABS-II also measures daily 
living skills and motor skills, and is therefore not diagnostic of or specific to ASD. The 
present study indicates that the ADOS CSS mitigates the influence of adaptive behavior on 
ASD severity to a greater degree than the other measures of ASD severity. Thus, the ADOS 
CSS may be a metric that is relatively free of the impact of adaptive behavior skills 
compared to the ADOS total score and SEED DOI.
Expressive language abilities as measured by the MSEL also explained a significant amount 
of variance of ASD symptom severity for all three severity outcomes. This finding could be 
due to the challenges of appraising expressive language skills (e.g., describing events, 
labeling objects, and using appropriate grammar) separate from pragmatic language skills 
(e.g., engaging in conversation and using verbal and non-verbal language to initiate and 
maintain social interactions). Indeed, the most common first concern among parents of 
children with ASD is delayed language development (Kozlowski et al. 2011). However, the 
diagnostic features of ASD focus on the social use of language rather than the practical use 
of language, even though expressive language delay is a frequent co-occurring condition. 
The ADOS CSS mitigates the influence of expressive language abilities on ASD severity 
ratings more than do other severity outcomes (Tables 2, 3, 4). Consequently, the ADOS CSS 
may be a more accurate measure of difficulties with social communication versus problems 
with expressive language than the ADOS total score and SEED DOI.
Internalizing behavior problems and fine motor delays were significantly associated with the 
ADOS CSS, ADOS total score, and SEED DOI. These findings replicate recent research that 
highlights an association between ASD severity and avoidant behaviors (Jang and Matson 
2015). The CBCL internalizing behavior problem scale—which was used as a measure of 
internalizing behaviors in this study— is comprised of emotional reactivity, anxiety/
depression, somatic complaints, and withdrawn behavior. Items on these subscales overlap 
with ASD diagnostic features captured on the ADOS (e.g., avoids eye contact, disturbed by 
change, and little interest in others). Clinicians and parents may therefore recognize similar 
symptoms in the child that are noted by the parent on the CBCL and noted by the clinician 
on the ADOS and SEED DOI. Early motor delays have been implicated in the subsequent 
development of ASD (Flanagan et al. 2012) and ASD severity ratings (MacDonald et al. 
2014), although the relationship between ASD severity and fine motor delays is sparse. The 
association between fine motor delays and ASD severity should be investigated in future 
research.
In terms of demographic and other variables included in the analyses, maternal education 
and SEED site were also significantly associated with the ADOS CSS, ADOS total score, 
and SEED DOI. Distribution of severity by site may vary due to many factors, including 
sources utilized for case identification and site specific recruiting practices. Importantly, the 
SEED study used an extremely robust quality control procedure to ensure consistency of 
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ADOS scoring across sites. However, even with reliable coding on standardized diagnostic 
instruments, there are likely to be differences in the characteristics of state populations that 
are associated with and could impact severity. Our observation that maternal education 
impacts ASD severity regardless of outcome measure suggest that maternal education should 
be accounted for in future analyses.
Developmental characteristics, particularly adaptive abilities and expressive language skills, 
explained the most amount of variance in the SEED DOI outcome, indicating that clinicians 
respond to global child functioning more than diagnostic features of ASD when estimating 
ASD symptom severity. This is not surprising given that many clinicians are trained to focus 
on the whole child when determining global severity ratings, and adaptive and language 
delays could be especially impairing. Clinical ratings of the core symptoms of ASD 
independent from adaptive, language, or other child characteristics might require specific 
training. Further, reliability and validity of those ratings would need to be demonstrated.
CBCL externalizing behavior problems were significant factors in the ADOS CSS and 
ADOS total score, but not the SEED DOI. Attention problems and aggressive behavior 
could impact ADOS items such as quality of social overtures and quality of rapport, whereas 
attention problems and aggressive behavior could be viewed by clinicians as associated 
features of ASD. This again suggests that clinicians making global ratings could find it 
useful to consider the type of impairment they are capturing when assessing ASD severity.
This study had a number of strengths and limitations. The sample size was large and 
represented participants from multiple geographic locations. Children were classified as 
ASD after a comprehensive evaluation conducted by clinicians who established and 
maintained research reliability on diagnostic instruments. Results are comparable with 
previous research and suggest the ADOS CSS best measures ASD symptom severity while 
controlling for the influence of other developmental and demographic factors. A few 
limitations were noted. SEED site was a significant predictor of ASD symptom severity 
despite outcome measure and reliability standards. Higher maternal education also predicted 
higher ASD severity scores. These findings can help guide future research on ASD severity 
in young children.
In sum, we found that the ADOS CSS effectively measures ASD symptom severity in pre-
school children from multiple geographic areas. The ADOS CSS is less impacted by 
developmental and demographic factors than the ADOS total score or clinician ratings. We 
thus conclude that the ADOS CSS is an appropriate measure for ASD symptom severity in 
clinical, epidemiological, and treatment research; although purpose should be considered 
when selecting a severity measure in pre-school children.
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Table 1
Bivariate correlations between the Autism Diagnostic Observation Schedule (ADOS) calibrated severity score 
(CSS), ADOS total score, and degree of impairment associated with ASD in the Study to Explore Early 
Development (SEED DOI)
ADOS CSS ADOS total score SEED DOI
ADOS CSS – 0.87a 0.52a
ADOS total score – – 0.73a
SEED DOI – – –
aCorrelation is significant at the 0.01 level
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